Chemical activators of V1RD20 engage in a variety of signaling pathways to drive the activation of this protein. The activation process often centers around the regulation of second messengers such as cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP), which are crucial for the activation of protein kinases that in turn activate V1RD20. Forskolin, for example, directly stimulates adenylyl cyclase, resulting in elevated levels of cAMP. This surge in cAMP activates protein kinase A (PKA), which can phosphorylate V1RD20, leading to its activation. Similarly, IBMX works by inhibiting phosphodiesterases, which normally degrade cAMP, thereby prolonging the activation of PKA and ensuring prolonged phosphorylation and activation of V1RD20. Prostaglandin E2 binds to its specific EP receptors that operate through adenylyl cyclase to increase cAMP, thus employing PKA to phosphorylate and activate V1RD20. Histamine, through its action on H2 receptors, and Epinephrine, via beta-adrenergic receptors, both escalate cAMP levels, further enabling PKA to activate V1RD20. Isoproterenol, another beta-adrenergic agonist, also raises cAMP concentrations, fostering a conducive environment for PKA-mediated activation of V1RD20.
The influence of cGMP is also pivotal in the activation of V1RD20. Vardenafil, by inhibiting phosphodiesterase type 5, leads to an increase in cGMP levels, which in turn activates protein kinase G (PKG). PKG can phosphorylate and activate V1RD20 in a similar fashion to PKA. Sodium Nitroprusside, by releasing nitric oxide, stimulates guanylyl cyclase to produce cGMP, thereby activating PKG which then goes on to phosphorylate and activate V1RD20. Anisomycin activates the JNK signaling pathway, which includes kinases that can directly phosphorylate and activate V1RD20. Angiotensin II activates the AT1 receptor, which triggers the phospholipase C (PLC) pathway, leading to the activation of protein kinase C (PKC), another kinase which can phosphorylate and activate V1RD20. Diacylglycerol, as an endogenous activator of PKC, also facilitates the phosphorylation and consequent activation of V1RD20. These diverse chemical activators, through their specific actions on various signaling molecules and pathways, ensure the functional activation of V1RD20 by a complex network of intracellular events.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Activates adenylyl cyclase, leading to an increase in cAMP levels which can activate PKA, and PKA can phosphorylate and activate V1RD20. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
Inhibits phosphodiesterases, preventing cAMP breakdown, which sustains PKA activity that can phosphorylate and activate V1RD20. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $56.00 $156.00 $270.00 $665.00 | 37 | |
Binds to EP receptors that signal through adenylyl cyclase to increase cAMP, activating PKA that can then phosphorylate and activate V1RD20. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $92.00 $277.00 $969.00 | 7 | |
Binds to H2 receptors, increasing cAMP and activating PKA, which can phosphorylate and activate V1RD20. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $40.00 $102.00 $197.00 $1739.00 $16325.00 | ||
Engages beta-adrenergic receptors to increase cAMP levels, leading to PKA activation that can phosphorylate and activate V1RD20. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
A beta-adrenergic agonist that increases cAMP, thus activating PKA which can phosphorylate and activate V1RD20. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $33.00 $47.00 $294.00 $561.00 $1020.00 $2550.00 $4590.00 | 1 | |
Interacts with A2A receptors to elevate cAMP levels, engaging PKA in the phosphorylation and activation of V1RD20. | ||||||
Vardenafil | 224785-90-4 | sc-362054 sc-362054A sc-362054B | 100 mg 1 g 50 g | $516.00 $720.00 $16326.00 | 7 | |
Inhibits phosphodiesterase type 5, increasing cGMP levels and activating PKG which can phosphorylate and activate V1RD20. | ||||||
Sodium nitroprusside dihydrate | 13755-38-9 | sc-203395 sc-203395A sc-203395B | 1 g 5 g 100 g | $42.00 $83.00 $155.00 | 7 | |
Releases nitric oxide to stimulate guanylyl cyclase, increasing cGMP and activating PKG which can phosphorylate and activate V1RD20. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Activates the JNK signaling pathway, which includes kinases that can phosphorylate and activate V1RD20. |